TheraVet SA Logo

TheraVet SA

ISIN

BE0974387194

Ticker

ALVET

Sector

Health Care

Sub-Industry

Pharmaceuticals

Country

Belgium

Year Founded

2017

About TheraVet SA

Company Description

TheraVet is a vet biotech company headquartered in Belgium (Jumet, Wallonia) with an US-based subsidiary.

TheraVet's mission is to develop innovative, safe and effective treatments to improve the well-being and quality of life of companion animals suffering from osteoarticular diseases.

TheraVet's main targets (indications & applications) are osteoarthritis, ligament & tendon injuries and bone surgery in cats and dogs as well as horses.

TheraVet works in close collaboration with key opinion leaders in Belgium and abroad (France, Switzerland, United Kingdom & United States) to better address the ever-increasing needs of veterinary medicine.

Served Area

Worldwide

Headquarters

Avenue Jean Mermoz 32/1
6041, Charleroi, Hainaut
Belgium

Insider Trades

Date Trading entity / Person Association Trade type Volume
21.11.2023 Bastianelli Enrico Board Other EUR 380,000.00

Capital Markets Information

ISIN

BE0974387194

LEI

984500804EBR3F1EFF71

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

Euronext Brussels

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.